片消费对伊朗患者前列腺癌的影响:一项追溯分析研究
Reza Mohammadi1, Mahbobeh Mirzaei1, Ali Tajik Ghanbari1
1Department of Urology, School of Medicine, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran.
Medicine
|March 13, 2026
概括
伊朗男性使用片与较低的前列腺癌检测率和较低的PSA水平有关. 然而,片消费与更先进的癌症阶段或特征没有相关性.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 毒理学 毒理学 毒理学
背景情况:
- 前列腺癌是伊朗男性的主要癌症.
- 片的使用在伊朗很普遍,被列为第一组致癌物.
- 了解片和前列腺癌之间的联系对于公共卫生至关重要.
研究的目的:
- 调查片消费与前列腺活检结果之间的关联.
- 评估片使用对前列腺癌检测和病理特征的影响.
主要方法:
- 一项对441名接受前列腺活检的男性进行了回顾性横截面研究.
- 患者被分为片使用者 (n=143) 和非使用者 (n=298).
- 分析了人口统计数据,PSA水平,前列腺体积,格里森得分和癌症阶段.
主要成果:
- 与片使用者 (53.1%) 相比,非使用者 (63.8%) 发现了活检确认的前列腺癌的比例明显更高.
- 非使用者 (54.22 ± 1.64) 的PSA平均水平明显高于片使用者 (52.28 ± 2.64).
- 两组之间在前列腺体积,格里森评分或癌症阶段方面没有发现显著差异.
结论:
- 片消费与较低的PSA水平和较低的前列腺癌检测率有关.
- 片使用与前列腺癌更先进的临床或病理特征没有关联.
- 需要进一步的研究来阐明片对PSA水平和诊断精度的生物学影响.
相关概念视频
Analgesia and Pain Management
2.7K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.3K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.3K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
809
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
809
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Opioid Receptors: Overview
6.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.0K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
324
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
324


